Internal Medicine Doctors in Mishawaka, IN Accepting Medicare

56 Internal Medicine doctors found. Showing 41 - 56

Dr. Brian Scott Sucharetza, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 515 Park Place, Suite 200, Mishawaka, IN 46545 Phone: 574-607-4724    Fax: 574-607-4725

Dahan Hussein Al-fadhl, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas, Suite 309, Mishawaka, IN 46545 Phone: 574-335-6232    Fax: 574-335-6233

Joshua Bowling, M.D. Internal Medicine - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E Day Rd, Mishawaka, IN 46545 Phone: 574-234-8161

Richard Joel Wein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3625 Park Pl W, Ste 100, Mishawaka, IN 46545 Phone: 574-232-5963    Fax: 574-287-7988

Dr. Sachin R. Patel, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 208, Mishawaka, IN 46545 Phone: 574-335-6700    Fax: 574-335-0726

Dr. Pravin Pratap, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 208, Mishawaka, IN 46545 Phone: 574-335-6700    Fax: 574-335-0726

Dr. Swarupa Rani Eskapalli, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 710 Park Pl, Nephrology Physicians Llc, Mishawaka, IN 46545 Phone: 574-273-6767

John M Decelles, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 611 E Douglas Rd, Suite 309, Mishawaka, IN 46545 Phone: 574-472-6450    Fax: 574-472-6474

Fei Lu, MD Internal Medicine - Clinical Cardiac Electrophysiology Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 208, Mishawaka, IN 46545 Phone: 574-335-6700    Fax: 574-335-0726

Dr. Henry Wu, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 710 Park Pl, Mishawaka, IN 46545 Phone: 574-273-6787    Fax: 574-968-7160

Robin T Zon, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5340 Holy Cross Pkwy, Mishawaka, IN 46545 Phone: 574-237-1328    Fax: 574-237-1348

Shaya Mokfi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15011 Day Rd, Mishawaka, IN 46545 Phone: 574-855-4310    Fax: 574-855-4313

Dr. James L Porile, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 710 Park Place, Mishawaka, IN 46545 Phone: 574-273-6787    Fax: 574-968-0882

Owais Mufti, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4455 Edison Lakes Pkwy # 100, Mishawaka, IN 46545 Phone: 574-231-6800

Dr. Michael James Phend, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5215 Holy Cross Parkway, Mishawaka, IN 46545 Phone: 574-237-7168    Fax: 574-472-6262

Dr. Aerie Chung, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3838 N Main St Ste 1c, Mishawaka, IN 46545 Phone: 574-404-3980    Fax: 574-931-8601

News Archive

FDA advisory committee recommends that FDA wait for overall survival results from Satraplatin phase 3 trial

GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.

BUSM researchers discover new gene therapy for treating emphysema patients

Researchers from Boston University School of Medicine (BUSM) have discovered a new gene therapy that may prevent the progression of emphysema. The study, which appears on-line in the Journal of Clinical Investigation, describes a method to express therapeutic genes in lung tissue for a lifetime after only a single treatment.

Recruitment complete in Aeterna Zentaris' perifosine Phase 3 trial for advanced colorectal cancer

Aeterna Zentaris Inc. today announced the completion of patient recruitment for the ongoing Phase 3 trial with perifosine in refractory advanced colorectal cancer.

SARS-CoV-2 gene deletions may cause milder infections and increase human-to-human transmission

In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3(current)